Umeå University

Umeå University was founded in 1965 and is Sweden’s fifth oldest university. Today, it has a strong international presence with students, teachers and researchers from all over the world. With 37000 students from 60 countries the aim of the university is to continue becoming one of best environments for study and research and meet the challenges of an ever-increasing global society. Umeå University is one of Sweden’s most comprehensive universities within all areas of scientific research and education. The research takes place on a broad scale in order to compete in the international arena. The university conducts ground-breaking research within several areas e.g. Life science, Medicine, Gender research, Biological Chemistry, Ecosystem Dynamics, Energy, Infections, Plant and Forest Biotechnology and Social Welfare Research. It is also a hub for research in AI and also in ethics in AI. Furthermore, Umeå University has a strong and established interdisciplinary interest in sustainability. The medical faculty is the largest faculty at the university, with research in the forefront in radiation treatment, prostate cancer, neuroscience including imaging and paediatrics especially in preterm born and nutrition. The environment for clinical research is good and has received highest score in international evaluation. Our centrum, Molecular infection medicine Sweden ( is partner in Nordic EMBL node and we are also one of four parts in Wallenberg Center for molecular medicine (WCMM) in Sweden. WCMM conducts research in cancer, infection biology, neuroscience and metabolic disorders including diabetes and is part of a nationwide effort to strengthen molecular life science in an initiative by the Knut and Alice Wallenberg Foundation (KAW). Other funded research from KAW are the large projects WASP-AI, WASP-HS and Data driven life science (DDLS) that foster fellow researchers and build research infrastructures for the aimed research. The university and university hospital are physically located side by side and the structures for collaboration is very well developed.

Role of institution in the project

UmU is mainly involved in WP7 Use cases for platform expansion and validation, which is led by professor Katrine Riklund but UmU will also contribute to tasks T1.3 Engagement with Cancer Care professionals and patient associations, T3.2 Ethical compliance, T4.4 Central storage and development infrastructure, T5.3 The EUCAIM Data Preprocessing tools and services and WP8 Business & Sustainability models.

Dr. Katrine Riklund

Dr Katrine Riklund is a full professor and senior clinical physician in radiology and nuclear medicine at UMU and RegVB. She is pro vice chancellor of UMU with responsibilities including research and research infrastructures. She chairs the high-performance computing center, and the center of transdisciplinary AI at UMU. She is an expert in hybrid imaging with focus on cancer imaging. She is the past president of ECR, ESR and ESHI as well as of the Swedish Society of Radiology and the Swedish Society of Nuclear Medicine. She is chairing several national research infrastructures, including the Center for Medical Image Science and Visualization at Linköping University, the Center for Functional Brain Imaging at Umeå University, and the Wallenberg Center for Molecular Medicine at the same university. She is an ordinary board member of the national facilities SciLifeLab and the scientific board of the Swedish Drug Authority. She has served as grant evaluator for the Swedish Radiation Safety Authority, the Swedish Cancer Society and the Swedish Research Council and has received honorary memberships from the French Society of Radiology and the RSNA and received the Alfred Breit price from the German Radiology Society in 2019.

Beatrice Melin

Beatrice Melin is Professor of Oncology and Director of PREDICT a infrastructure for precision health. Professor Melin is also Director of Research Development Innovation.

Miriam Rutegård

Miriam Rutegård is a PhD student and specialist in radiology.

Join the EUCAIM Consortium

Open Call for New Beneficiaries

We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.

Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.

Apply by 10 June 2024!

Open Call Webinar

We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

March 14, 10:00-11:30 aM CET



Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.